Navigation Links
GATA: a graphic alignment tool for comparative sequence analysis

Sometimes a potential target for a drug seems very promising on paper; things are often very different in reality. Its the case of telomerase inhibitors to treat cancer; they are supposed to strip the "immortal" (able to divide indefinitely) aspect of cancer cells. Yet, something in the cell seems to block their function, preventing them to inhibit completely the telomerase. What to do then? Scrap the project? Look for something else? Hell no! Look out for whats stopping the drug! Perseverance is sometimes worth it, as we can see. A new research study published in the January issue of Cancer Cell provides exciting new information about how to boost the effectiveness of a promising cancer treatment that targets telomeres in an attempt to interfere with the ability of a cancer cell to continuously divide.

Telomeres are DNA sequences found at the ends of chromosomes that play a key role in controlling the life span of cells. With every cell division, telomeres get a bit shorter until eventually they become so short that the enzymes that copy DNA for cell division no longer work properly and the cell stops dividing. In a sense, telomeres function as a kind of counting mechanism that regulates how many times a cell can divide. In contrast to normal cells, cancer cells divide continuously and uncontrollably. Scientists know that cancer cells produce an enzyme, called telomerase, which prevents telomeres from getting too short so cells can keep dividing. Telomerase is not used by healthy cells, and has been identified as a logical target for anticancer therapeutics. However, recent studies indicate that for this therapy to be effective, telomeres must be in a critically short state, requiring an extended treatment duration that can lead to drug resistance and other problems. Dr. Hiroyuki Seimiya from the Japanese Foundation for Cancer Research in Tokyo and colleagues examined what happens to cancer cells when telomerase inhib
'"/>

Source:


Page: 1 2

Related biology news :

1. International Team Determines Geographic Origin of Leprosy
2. Past droughts geographically widespread in the West, according to tree-ring data
3. Use of stone hammers sheds light on geographic patterns of chimpanzee tool use
4. Preliminary study finds holographic imaging system promising for cancer treatment planning
5. New comparative toxicogenomics database
6. Viral DNA sequence a possible trigger for breast cancer
7. Found: Missing sequence of the human Y chromosome
8. Researchers uncover sequence of major rice pathogen
9. Agilent Technologies releases probe sequence, annotation information for all its commercial gene expression microarrays
10. Oldest fossil human protein ever sequenced
11. Deep thinking: Scientists sequence a cold-loving marine microbe

Post Your Comments:
(Date:11/4/2009)... scientists are reluctant to officially endorse gr...ntinues to grow about its protective effects, incl...Prevention Research , a journal of the American As... reduction in oral cancer. , Vassiliki Papadimi...artment of Thoracic/Head and Neck Medical Oncology...
(Date:11/4/2009)...s in the cities of Long Beach and Riverside are re...ble childhood asthma, and the true impact of air p...ely been underestimated, according to researchers ..., The study, which appears in an online edition o...ed that nine percent of all childhood asthma cases...
(Date:11/4/2009)...bacteria, it turns out, hold the power to help mil...the world clean up toxic waste on test sites. , ...ere invented back in World War II and have been us...energy compounds are often used to propel tank she... , But with increased knowledge of their environ...
Breaking Biology News(10 mins):Does green tea prevent cancer? Evidence continues to brew, but questions remain 2USC study finds big air pollution impacts on local communities 2Genomic research will enable greener cleanup of military explosive test sites 2China Biotics Inc Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Financial Results 12968 1China Biotics Inc Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Financial Results 12968 2Shoulder Surgery Helps Athletes Get Back in the Game 51319 1Shoulder Surgery Helps Athletes Get Back in the Game 51319 2More Mammograms May Mean More Harmless Cancers 51316 1More Mammograms May Mean More Harmless Cancers 51316 2
...the widely held belief that engaging in sexual int...asten labor and delivery. , In fact, just the oppo...iversity Medical Center. Women who were sexually a...s carried their babies an average of 39.9 weeks, c...men who abstained from sexual activity at term. ,...
...wly created by the University of California, Berke...NL) aims to put light-sensitive switches in the bo...y as a remote control operates a TV. , Optical swi..., initiate a muscle contraction, activate a drug o...ight. , One major goal of the UC Berkeley-LBNL N...
...autism remain complex and mysterious, researchers .... In what they believe to be a significant new app... (ASD), researchers have developed a mouse that sh...ophy characteristic of the disease. , In an articl...colleagues report the results of removing (knockin...
Other Biology News:Study challenges myth that sex late in pregnancy hastens birth 2Light-sensitive photoswitches could restore sight to those with macular degeneration 2Light-sensitive photoswitches could restore sight to those with macular degeneration 3Mutant mice show key autism traits 2
(Date:11/6/2009)...RNewswire/ -- Intarcia Therapeutics, Inc. delivere...174; continuous delivery of exenatide) program for...ual Diabetes Technology Meeting in San Francisco, ...rnh/20050301/SFTU126LOGO ) ,, Continuous Subc... Plasma Glucose, HbA1c and Reduces Weight in a 28-...
(Date:11/5/2009)... The endangered black-footed ferret...his rare carnivore feeds on prairie dogs. The pr...n entire population die-offs in towns occur. The ...nted a ferret breeding program and has been releas...ative habitat. Unfortunately, plague can sweep th...
(Date:11/5/2009)...y, November 5, 2009 at 4:30 p.m. Eastern Time ,...rstCall/ - OncoGenex Pharmaceuticals, Inc. ("OncoG...orted unaudited financial results for the third qu... reviewed the Company,s highlights for the third q...esults reflect the operations of OncoGenex Technol...
(Date:11/5/2009)... Wound Management Technol...ntered into a Letter of Intent to purchase all hea...ies, Inc. (OTC Bulletin Board: VHGI). The deal pro...ebt, 4,000,000 shares of WNDM and a royalty agreem...p technology being acquired from VHGI. WNDM clos...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
... BEDFORD, Mass., March 30 GSI Group Inc. (Nasdaq:...semiconductor systems, today announced that it has...ition of revenue from sales to certain customers i...year 2006. The Audit Committee of the Board of Dir...f potential adjustments resulting from the identif...
... BUENOS AIRES, Argentina, March 30 The Develo...d Table on Responsible Soy Association,(RTRS) met ... final document,on "Responsible Soy Principles and...cgi-bin/prnh/20090330/ARM001LOGO ) , Such doc...ational,Conference in the city of Campinas, Brazil...
... WOBURN, Mass., March 30 BioVex Inc, a company de...t and prevention of cancer and infectious disease,...first close of a series F private financing. , , ... who were joined by other existing investors inclu...Harris Group, Innoven Partners, New Science Ventur...
Other Biology Technology:GSI Group Inc. to Restate Financial Results for 2006 2International Soy Experts Meeting in Argentina Called by the Round Table on Responsible Soy Association (RTRS) 2BioVex Raises $40 Million in First Close of Series F Financing 2BioVex Raises $40 Million in First Close of Series F Financing 3
Rabbit Anti-Human MMP-7, aminoterminal end active enzyme, Antibody, Unconjugated from CEDARLANE Laboratories Limited
Rabbit Anti-Factor IX Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human Lipid Phosphate Phosphohydrolase 2 Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Rabbit Anti-Phosphothreonine-Proline / Phosphoserine-Proline Polyclonal Antibody, Unconjugated from Abcam
Biology Products: